Wednesday, April 13, 2022 12:24:39 AM
True, CAC scan is a lagging indicator. A high score means a history of plaque, but risk of ongoing buildup of new plaque needs to be investigated. So understand, my score at age 68 was zero.
From “Slate”:
“A physical conducted in 2018 found that the president had moderate heart disease. In a routine coronary calcium CT scan, he had a score of 133. Anything over 100 indicates a buildup of plaque, and therefore coronary artery disease.”
From Mayo Clinic:
“The result of the test is usually given as a number called an Agatston score. The score reflects the total area of calcium deposits and the density of the calcium.
A score of zero means no calcium is seen in the heart. It suggests a low chance of developing a heart attack in the future.
When calcium is present, the higher the score, the higher your risk of heart disease.
A score of 100 to 300 means moderate plaque deposits. It's associated with a relatively high risk of a heart attack or other heart disease over the next three to five years.
A score greater than 300 is a sign of very high to severe disease and heart attack risk.
You also may receive a percentile score, which indicates your amount of calcium compared to people of the same age and sex.”
Lives could be saved if a CAC scan at age 50 was standard procedure. But Nissen did everything thing he could to kill it. He failed ultimately but tainted it so that only that rare spotted purple unicorn cardiologist who believes in prevention will prescribe them.
As for my LDL, statins aren’t an option. Had been taking 10 mg Lipitor but had a rhabdo episode when increasing running intensity. Tried 5 mg Crestor, but no go. Not really interested in a Vascepa combo pill. Like you, I think it’s a dumb idea. Meanwhile, I’m more interested in controlling the hypertension.
From “Slate”:
“A physical conducted in 2018 found that the president had moderate heart disease. In a routine coronary calcium CT scan, he had a score of 133. Anything over 100 indicates a buildup of plaque, and therefore coronary artery disease.”
From Mayo Clinic:
“The result of the test is usually given as a number called an Agatston score. The score reflects the total area of calcium deposits and the density of the calcium.
A score of zero means no calcium is seen in the heart. It suggests a low chance of developing a heart attack in the future.
When calcium is present, the higher the score, the higher your risk of heart disease.
A score of 100 to 300 means moderate plaque deposits. It's associated with a relatively high risk of a heart attack or other heart disease over the next three to five years.
A score greater than 300 is a sign of very high to severe disease and heart attack risk.
You also may receive a percentile score, which indicates your amount of calcium compared to people of the same age and sex.”
Lives could be saved if a CAC scan at age 50 was standard procedure. But Nissen did everything thing he could to kill it. He failed ultimately but tainted it so that only that rare spotted purple unicorn cardiologist who believes in prevention will prescribe them.
As for my LDL, statins aren’t an option. Had been taking 10 mg Lipitor but had a rhabdo episode when increasing running intensity. Tried 5 mg Crestor, but no go. Not really interested in a Vascepa combo pill. Like you, I think it’s a dumb idea. Meanwhile, I’m more interested in controlling the hypertension.
Recent AMRN News
- Amarin to Report First Quarter 2026 Financial Results and Host Conference Call on April 29, 2026 • GlobeNewswire Inc. • 04/15/2026 12:00:00 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/10/2026 09:01:34 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/10/2026 09:00:20 PM
- American College of Cardiology (ACC) Scientific Sessions 2026 Underscore the Need for Complementary Therapies Including Icosapent Ethyl (IPE) in Treatment of Elevated Triglycerides and Cardiovascular Risk Reduction • GlobeNewswire Inc. • 04/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/02/2026 08:30:11 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/30/2026 09:57:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/27/2026 09:00:07 PM
- Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline • GlobeNewswire Inc. • 03/18/2026 12:30:00 PM
- New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual Scienti • GlobeNewswire Inc. • 03/16/2026 12:15:00 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/02/2026 10:31:01 PM
- Effects of Icosapent Ethyl on Risk and Duration of Hospitalizations and Death in REDUCE-IT® Post Hoc Analysis Published in the European Journal of Preventive Cardiology • GlobeNewswire Inc. • 03/02/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/25/2026 12:05:26 PM
- Amarin Reports Fourth Quarter and Full Year 2025 Financial Results • GlobeNewswire Inc. • 02/25/2026 12:00:00 PM
- This American Heart Month Amarin Spotlights the Need to Prioritize Proven Widely Available Yet Underutilized Therapies in the Battle Against Cardiovascular Disease • GlobeNewswire Inc. • 02/23/2026 01:00:00 PM
- Amarin to Report Fourth Quarter and Full Year 2025 Financial Results and Host Conference Call on February 25, 2026 • GlobeNewswire Inc. • 02/11/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:09 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:07 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:06 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:05 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 12:00:04 AM
- Amarin Applauds Breakthroughs In Therapies For Patients With Elevated Triglycerides; Company’s VASCEPA®/VAZKEPA® (Icosapent Ethyl) Franchise Well Positioned To Benefit Globally From Broadened Category Commercialization • GlobeNewswire Inc. • 01/09/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 12:05:27 PM
- Amarin Announces Preliminary 2025 Financial Highlights and Operational Accomplishments, Including Achieving Positive Cash Flow; Company Well Positioned to Capture Global Growth Opportunities • GlobeNewswire Inc. • 01/08/2026 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:21 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/06/2026 10:00:17 PM
